Literature DB >> 16079833

Tumour biology: senescence in premalignant tumours.

Manuel Collado1, Jesús Gil, Alejo Efeyan, Carmen Guerra, Alberto J Schuhmacher, Marta Barradas, Alberto Benguría, Angel Zaballos, Juana M Flores, Mariano Barbacid, David Beach, Manuel Serrano.   

Abstract

Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079833     DOI: 10.1038/436642a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  578 in total

1.  PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway.

Authors:  Naoto Yoshizuka; Maoyi Lai; Rong Liao; Ryan Cook; Changchun Xiao; Jiahuai Han; Peiqing Sun
Journal:  Mol Cancer Res       Date:  2012-06-04       Impact factor: 5.852

Review 2.  Using mice to examine p53 functions in cancer, aging, and longevity.

Authors:  Lawrence A Donehower
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11-04       Impact factor: 10.005

3.  Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita.

Authors:  Cristian Bellodi; Noam Kopmar; Davide Ruggero
Journal:  EMBO J       Date:  2010-05-07       Impact factor: 11.598

4.  Pirin inhibits cellular senescence in melanocytic cells.

Authors:  Silvia Licciulli; Chiara Luise; Gaia Scafetta; Maria Capra; Giuseppina Giardina; Paolo Nuciforo; Silvano Bosari; Giuseppe Viale; Giovanni Mazzarol; Chiara Tonelli; Luisa Lanfrancone; Myriam Alcalay
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

5.  WT1: a weak spot in KRAS-induced transformation.

Authors:  Silvia Licciulli; Joseph L Kissil
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

6.  Oncogene-induced senescence results in marked metabolic and bioenergetic alterations.

Authors:  Celia Quijano; Liu Cao; Maria M Fergusson; Hector Romero; Jie Liu; Sarah Gutkind; Ilsa I Rovira; Robert P Mohney; Edward D Karoly; Toren Finkel
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

Review 7.  Senescent cells: an emerging target for diseases of ageing.

Authors:  Bennett G Childs; Martina Gluscevic; Darren J Baker; Remi-Martin Laberge; Dan Marquess; Jamie Dananberg; Jan M van Deursen
Journal:  Nat Rev Drug Discov       Date:  2017-07-21       Impact factor: 84.694

Review 8.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

Review 9.  Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.

Authors:  Robert L Bowman; Lambert Busque; Ross L Levine
Journal:  Cell Stem Cell       Date:  2018-02-01       Impact factor: 24.633

10.  Geriatric muscle stem cells switch reversible quiescence into senescence.

Authors:  Pedro Sousa-Victor; Susana Gutarra; Laura García-Prat; Javier Rodriguez-Ubreva; Laura Ortet; Vanessa Ruiz-Bonilla; Mercè Jardí; Esteban Ballestar; Susana González; Antonio L Serrano; Eusebio Perdiguero; Pura Muñoz-Cánoves
Journal:  Nature       Date:  2014-02-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.